Affiliate Members

It received the prestigious Prix Galien award for best start-up in biotech in 2022 and was granted both Breakthrough Therapy Designation (BTD) and Regenerative Medicine for Advanced Therapy (RMAT) by the U.S. FDA in June 2024 for its’ endothelial cell therapy program. Aurion Biotech developed and has launched the first commercially available corneal endothelial cell therapy in Japan as of the fall of 2024 and is currently set to initiate the U.S. Phase 3 Clinical Trial in 2026. To learn more, visit www.aurionbiotech.com.

Brightstar Therapeutics is the first company to offer a long-term solution for patients with impaired ocular healing through the BrightMEM corneal allograft, and we will continue to drive next-generation therapeutics for patients in need.

Our high complexity testing laboratories offer Donor Eligibility Screening, HLA/Immunogenetics and Microbiology Testing, using the most appropriate regulated testing technologies for the transplant and medical communities. Eurofins DPT offers a robust Quality Program- FDA-registered for HCT/Ps, certifications, licenses, and accreditation’s for CLIA, State Agencies, ASHI, Therapeutic Goods Administrations (TGA), German Health Authority. Eurofins DPT HCT/P regulated testing for all donor suitability and eligibility determination requirements. We offer all testing under one lab for ease of result reporting, customer support, IT integration and logistics.

The Eurofins DPT Difference:

• Complete test menu of HCT/P infectious disease testing for donor screening. All required regulated testing needed for both deceased and living donor eligibility determination.
• Robust Quality Program- FDA-registered for HCT/Ps, certifications, licenses and accreditation’s for CLIA, State Agencies, ASHI, Therapeutic Goods Administrations (TGA), German Health Authority.
• Regional testing laboratories; Denver, CO, Atlanta, GA, Boston, MA, Dallas, TX, Honolulu, HI, Los Angeles, CA, Minneapolis, MN, Philadelphia, PA, San Ramon, CA and Winston-Salem, NC.
• 24/7/365 dedicated customer testing support. • STAT and routine testing for expedited results.
• Result delivery to accommodate your needs: email, information system interface and portal. Our DPT Mission: Inspired to serve our communities as responsible Stewards of the Gift by delivering reliable testing services that save and enhance lives.

More than 15,000 medical professionals use our solutions at over 100 donation and transplant agencies worldwide. With the integration of electronic medical records, analytics, communications, and logistics tracking, an ecosystem is created to make tissue transplantation and research easier.